Global Respiratory Disease Diagnostics Market 2023-2029
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global respiratory disease diagnostics market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, test type, disease, end user, and region. The global market for respiratory disease diagnostics can be segmented by product: assays and reagents, instruments and devices, services and software. In 2022, the instruments and devices segment made up the largest share of revenue generated by the respiratory disease diagnostics market. Respiratory disease diagnostics market is further segmented by test type: imaging tests, in-vitro diagnostics tests, mechanical tests. The imaging tests segment was the largest contributor to the global respiratory disease diagnostics market in 2022. Based on disease, the respiratory disease diagnostics market is segmented into: asthma, chronic obstructive pulmonary disease (COPD), tuberculosis, others. The COPD segment is estimated to account for the largest share of the global respiratory disease diagnostics market. On the basis of end user, the respiratory disease diagnostics market also can be divided into: hospitals and clinics, reference laboratories, others. The hospitals and clinics segment held the largest share of the global respiratory disease diagnostics market in 2022 and is anticipated to hold its share during the forecast period. Respiratory disease diagnostics market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.
Market Segmentation
By product: assays and reagents, instruments and devices, services and software
By test type: imaging tests, in-vitro diagnostics tests, mechanical tests
By disease: asthma, chronic obstructive pulmonary disease (COPD), tuberculosis, others
By end user: hospitals and clinics, reference laboratories, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report also provides analysis of the key companies of the industry and their detailed company profiles including Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Inc., CAREstream Medical Ltd., COSMED S.r.l, F. Hoffmann- La Roche AG, Koninklijke Philips N.V., Medtronic plc, MGC Diagnostics Corporation, SDI Diagnostics Inc., Seegene, Inc., Thermo Fisher Scientific Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
To analyze and forecast the market size of the global respiratory disease diagnostics market.
To classify and forecast the global respiratory disease diagnostics market based on product, test type, disease, end user, region.
To identify drivers and challenges for the global respiratory disease diagnostics market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global respiratory disease diagnostics market.
To identify and analyze the profile of leading players operating in the global respiratory disease diagnostics market.
Why Choose This Report
Gain a reliable outlook of the global respiratory disease diagnostics market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY PRODUCT
Assays and reagents
Instruments and devices
Services and software
PART 6. MARKET BREAKDOWN BY TEST TYPE
Imaging tests
In-vitro diagnostics tests
Mechanical tests
PART 7. MARKET BREAKDOWN BY DISEASE
Asthma
Chronic obstructive pulmonary disease (COPD)
Tuberculosis
Others
PART 8. MARKET BREAKDOWN BY END USER
Hospitals and clinics
Reference laboratories
Others
PART 9. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America
PART 10. KEY COMPANIES
Abbott Laboratories
Becton, Dickinson and Company
bioMerieux SA
Bio-Rad Laboratories, Inc.
CAREstream Medical Ltd.
COSMED S.r.l
F. Hoffmann- La Roche AG
Koninklijke Philips N.V.
Medtronic plc
MGC Diagnostics Corporation
SDI Diagnostics Inc.
Seegene, Inc.
Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
2024 Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
USD 7500 View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
USD 2450 View Report2024 Global Respiratory Disease Testing Market
2024 Global Respiratory Disease Testing Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for Major Assays, Emerging Technologies and Trends, Instrumentation Pipeline, Growth Opportunities for Suppliers
USD 7500 View ReportGlobal Respiratory Virus Vaccines Market Research Report 2023-2027
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Respiratory Virus Vaccines Report by Material, Application, and Geography Global
USD 3200 View ReportFill The Form For Sample Request